Armata Pharmaceuticals Inc (ARMP)
2.59
-0.06
(-2.26%)
USD |
NYAM |
May 17, 16:00
2.64
+0.05
(+1.93%)
After-Hours: 20:00
Armata Pharmaceuticals Enterprise Value: 187.82M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 187.82M |
| May 16, 2024 | 189.99M |
| May 15, 2024 | 189.99M |
| May 14, 2024 | 199.75M |
| May 13, 2024 | 210.23M |
| May 10, 2024 | 205.94M |
| May 09, 2024 | 212.04M |
| May 08, 2024 | 193.96M |
| May 07, 2024 | 197.58M |
| May 06, 2024 | 184.92M |
| May 03, 2024 | 184.20M |
| May 02, 2024 | 184.20M |
| May 01, 2024 | 180.95M |
| April 30, 2024 | 186.37M |
| April 29, 2024 | 188.18M |
| April 26, 2024 | 193.96M |
| April 25, 2024 | 185.68M |
| April 24, 2024 | 184.56M |
| April 23, 2024 | 185.65M |
| April 22, 2024 | 184.92M |
| April 19, 2024 | 190.53M |
| April 18, 2024 | 186.31M |
| April 17, 2024 | 184.51M |
| April 16, 2024 | 209.80M |
| April 15, 2024 | 210.88M |
| Date | Value |
|---|---|
| April 12, 2024 | 211.61M |
| April 11, 2024 | 213.77M |
| April 10, 2024 | 217.03M |
| April 09, 2024 | 224.61M |
| April 08, 2024 | 224.61M |
| April 05, 2024 | 230.76M |
| April 04, 2024 | 228.59M |
| April 03, 2024 | 226.06M |
| April 02, 2024 | 226.42M |
| April 01, 2024 | 235.09M |
| March 28, 2024 | 219.88M |
| March 27, 2024 | 216.99M |
| March 26, 2024 | 214.82M |
| March 25, 2024 | 210.12M |
| March 22, 2024 | 203.97M |
| March 21, 2024 | 202.16M |
| March 20, 2024 | 196.75M |
| March 19, 2024 | 205.43M |
| March 18, 2024 | 193.13M |
| March 15, 2024 | 198.92M |
| March 14, 2024 | 190.88M |
| March 13, 2024 | 193.41M |
| March 12, 2024 | 200.63M |
| March 11, 2024 | 190.88M |
| March 08, 2024 | 197.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.594M
Minimum
Dec 28 2022
235.09M
Maximum
Apr 01 2024
84.63M
Average
78.28M
Median
May 12 2021
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 7.729M |
| Perspective Therapeutics Inc | 817.27M |
| Protalix BioTherapeutics Inc | 55.51M |
| Electromed Inc | 130.07M |
| Xtant Medical Holdings Inc | 116.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.02M |
| Total Expenses (Quarterly) | 10.23M |
| EPS Diluted (Quarterly) | -0.69 |
| Earnings Yield | -87.64% |
| Normalized Earnings Yield | -1627.07 |